177 related articles for article (PubMed ID: 36726926)
41. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
Ratliff TL; Palmer JO; McGarr JA; Brown EJ
Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: a case report and review of the literature.
Alvarez-Múgica M; Gómez JM; Vázquez VB; Monzón AJ; Rodríguez JM; Robles LR
J Med Case Rep; 2009 Sep; 3():7323. PubMed ID: 19918272
[TBL] [Abstract][Full Text] [Related]
43. Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.
Park CH; Jang MA; Ahn YH; Hwang YY; Ki CS; Lee NY
Korean J Lab Med; 2011 Jul; 31(3):197-200. PubMed ID: 21779195
[TBL] [Abstract][Full Text] [Related]
44. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges.
Holmes BJ; LaRue RW; Black JH; Dionne K; Parrish NM; Melia MT
Int J Mycobacteriol; 2014 Mar; 3(1):60-5. PubMed ID: 26786225
[TBL] [Abstract][Full Text] [Related]
45. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
Kudo T; Iwasa N; Maeda S; Mitarai S
Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
[TBL] [Abstract][Full Text] [Related]
46. Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.
Hsu CW; Chiu YC; Hu HY; Fan YH; Hong SC; Cheng WM
BMC Urol; 2020 Jul; 20(1):91. PubMed ID: 32641099
[TBL] [Abstract][Full Text] [Related]
47. Failed endovascular abdominal aortic aneurysm repair due to
Nishizawa M; Kudo T; Kijima T; Fujii Y
J Vasc Surg Cases Innov Tech; 2022 Dec; 8(4):807-812. PubMed ID: 36507086
[TBL] [Abstract][Full Text] [Related]
48. [Granulomatous pneumonia as a complication of intravesical BCG immunotherapy--a case report].
Rogoziński P; Taracha-Guz D; Pęcikiewicz P; Kachel T; Dubiel G; Wandzel P; Bruliński K
Pneumonol Alergol Pol; 2014; 82(2):163-9. PubMed ID: 24615200
[TBL] [Abstract][Full Text] [Related]
49. Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy.
Aslan G; Sevinc C; Tuna B; Ozkal S; Yorukoglu K
Indian J Urol; 2013 Jan; 29(1):70-2. PubMed ID: 23671372
[TBL] [Abstract][Full Text] [Related]
50. A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette-Guerin immunotherapy.
Kurokawa Y; Kawai T; Miyakawa J; Makise N; Akiyama Y; Yamada Y; Sato Y; Yamada D; Ushiku T; Kume H
IJU Case Rep; 2022 Jan; 5(1):45-47. PubMed ID: 35005471
[TBL] [Abstract][Full Text] [Related]
51. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
[TBL] [Abstract][Full Text] [Related]
52. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.
Martínez-Piñeiro L; Portillo JA; Fernández JM; Zabala JA; Cadierno I; Moyano JL; Solsona E; Unda M; Beardo P; Rodríguez-Molina J; Chantada V; Palou J; Muntañola P; Alonso Dorrego JM; Pérez-Garcia FJ; Silva JM; Chesa N; Montesinos M; Ojea A; Madero R; Martínez-Piñeiro JA
Eur Urol; 2015 Aug; 68(2):256-62. PubMed ID: 25794457
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases.
Umemoto T; Naruse J; Usui Y; Zakoji H; Miyakita H; Miyajima A
Case Rep Urol; 2021; 2021():5548054. PubMed ID: 34336352
[TBL] [Abstract][Full Text] [Related]
54. [Tuberculous prostatic abscess following intravesical bacillus Calmette-Guerin immunotherapy: a case report].
Ye HY; Xu QQ; Huang XB; Ma K; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):1039-41. PubMed ID: 26679674
[TBL] [Abstract][Full Text] [Related]
55. Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections.
Larsen ES; Joensen UN; Poulsen AM; Goletti D; Johansen IS
APMIS; 2020 Feb; 128(2):92-103. PubMed ID: 31755155
[TBL] [Abstract][Full Text] [Related]
56.
Jain H; Gada K; Zaidi S; Asiago-Reddy E; Eranki A
Proc (Bayl Univ Med Cent); 2019 Oct; 32(4):577-578. PubMed ID: 31656426
[TBL] [Abstract][Full Text] [Related]
57. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
[TBL] [Abstract][Full Text] [Related]
58. Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature.
Oladiran O; Nwosu I; Oladunjoye A; Oladunjoye O
J Community Hosp Intern Med Perspect; 2020 May; 10(2):168-170. PubMed ID: 32850058
[TBL] [Abstract][Full Text] [Related]
59. Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guérin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis.
Wu C; Zhou X; Miao C; Zhang J; Tang Q; Chang X; Ni H
Cell Physiol Biochem; 2017; 41(4):1298-1312. PubMed ID: 28278504
[TBL] [Abstract][Full Text] [Related]
60. A case of disseminated
Nishimura M; Okumura M; Takemasa T; Yoshiyama T; Tanaka Y; Saotome M; Ohta K
Respir Med Case Rep; 2023; 45():101902. PubMed ID: 37538979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
